PARK7/DJ1 anticorps (AA 167-189)

N° du produit ABIN636306

Cet anticorps anti-PARK7/DJ1 est un anticorps Lapin Polyclonal détectant PARK7/DJ1 dans WB et IHC. Adapté pour Humain.

Aperçu rapide pour PARK7/DJ1 anticorps (AA 167-189) (ABIN636306)

Antigène: PARK7/DJ1 (PARK7) (Parkinson Protein 7 (PARK7))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PARK7/DJ1 est non-conjugé

Application: Western Blotting (WB), Immunohistochemistry (IHC)

Détail du produit anti-PARK7/DJ1 anticorps

Épitope: AA 167-189

Réactivité croisée: Souris

Réactivité croisée (Details): This antibody also detects PARK7 (DJ-1) in mouse brain. Its immunogen shares 82 % sequence identity with Mouse, and rat DJ-1.

Purification: Affinity chromatography purified

Immunogène: PARK7 antibody was raised in rabbit using AA 167-189 (AIVEALNGKEVAAQVKAPLVLKD) of human PARK7 (DJ-1) as the immunogen.

Isotype: IgG

Information d'application

Indications d'application: IHC: 1:100-1:300, WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Concentration: Lot specific

Buffer: Affinity purified IgG supplied in PBS with 0.02 % NaN3.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.

Détails sur PARK7/DJ1

Antigène: PARK7/DJ1 (PARK7) (Parkinson Protein 7 (PARK7))

Autre désignation: PARK7

Sujet: Four chromosomal loci (PARK2, PARK6, PARK7, and PARK9) associated with autosomal recessive, early onset parkinsonism are known. Positional cloning within the refined PARK7 critical region recently identified mutations in the DJ-1 gene in PARK7-linked families. Mutations in the PARK7/DJ-1 gene cause autosomal-recessive Parkinsons disease.

Pathways: Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Proton Transport